Although IFN-γ enhances expression of these proteins in people without CGD [5–8] it obviously cannot enhance expression of oxidase proteins in individuals with gene defects that completely abolish expression of these proteins; nevertheless use of IFN-γ helps reduce serious infection in such individuals [4]. This evidence concerns the gene IFNG and chronic granulomatous disease.